
Orawis 75mg Tablet
Marketer
Merck Ltd
Salt Composition
Clopidogrel (75mg)
Overview Orawis 75mg Tablet
Cardiogard 75mg tablets are antithrombotic agents, reducing the risk of dangerous blood clot formation within blood vessels. This significantly lowers the likelihood of stroke or myocardial infarction. A common preventative medication for cardiovascular health, Cardiogard 75mg is prescribed to individuals at elevated risk of heart conditions. This includes patients with peripheral artery disease (circulatory issues from vascular narrowing), recent stroke or heart attack, cardiac arrhythmias, and those recovering from procedures like stent implantation. It’s also utilized adjunctively with other medications to manage heart attacks and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continued use is crucial, even during periods of well-being; discontinuation elevates the risk of stroke or heart attack. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Wound healing may be prolonged. While often mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active internal bleeding, such as from a peptic ulcer or intracranial hemorrhage. Prior to commencement, inform your physician of any history of bleeding disorders or recent major trauma/surgery. Temporary cessation may be necessary prior to scheduled surgery or dental procedures.
Primary Ingredients of Orawis 75mg Tablet
No text provided to rephrase.
Uses of Orawis 75mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Orawis 75mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Orawis 75mg Tablets can be ingested with or without food, however, consistent timing is recommended.
Common Side effects of Orawis 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Orawis 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Orawis 75mg Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Orawis 75mg Tablets can be taken with or without food, consistent timing is recommended.
How Orawis 75mg Tablet works:
CardioGuard 75mg tablets are antiplatelet agents that inhibit platelet aggregation, reducing the risk of dangerous thrombus development and consequently minimizing the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Orawis 75mg Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Orawis 75mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards prior to any prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Orawis 75mg tablets while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Orawis 75mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Orawis 75mg tablets are considered safe, and no dosage alteration is necessary.
LiverSAFE IF PRESCRIBED
For patients with liver impairment, Orawis 75mg tablets are considered safe, and no dosage modification is necessary.
What if you forget to take Orawis 75mg Tablet :
Should you forget a dose of Orawis 75mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orawis 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
